The role of protein tyrosine kinase (PTK) activity in the development of the retinal projection was examined in viva by applying inhibitors of cytoplasmic PTKs, herbimycin A and lavendustin A, to intact brain preparations of Xenopus embryos. The inhibitors were present during the period when retinal ganglion cell axons first navigate through the optic tract to reach their target, the optic tectum. A majority of inhibitor-treated retinal axons stalled at the beginning of the optic tract, leading to an 80% reduction in projection length at the highest doses. All inhibitor-treated axons that did extend into the optic tract exhibited normal pathfinding behavior. Tyrosine kinase assays of inhibitor-treated brains demonstrated that at doses at which retinal axon extension was severely impaired, PTK activity, including that of src family proteins, was reduced by 50-60%. Consistent with the in vivo findings, PTK inhibitors reduced neurite outgrowth from cultured retinal neurons by 70-80%. This contrasts with the strong enhancement of outgrowth induced by the same inhibitors in cultured chick ciliary ganglion neurons and suggests that the mediation of outgrowth by PTK activity may vary in different neuronal types. Inhibitor-treated growth cones cultured on laminin were larger than normal, suggesting that tyrosine phosphorylation can modulate growth cone-substrate adhesive interactions. Our results in vivo and in vitro provide complementary evidence that retinal axon outgrowth is inhibited by pharmacological blockers of PTK activity and indicate that inhibitor-sensitive PTKs normally play a role in promoting retinal neurite extension.
Extracellular cues provide the exploring tip of the retinal axon, the growth cone, with the molecular information needed to properly extend in the optic pathway (Bixby and Harris, 1991; Holt and Harris, 1993; Chien and Harris, 1994) . One possible mechanism by which these cues are transduced into meaningful signals is modulation of tyrosine phosphorylation. Phosphotyrosine is abundant in the process-rich layers of the embryonic chicken retina, optic tract, and optic tectum (Shores and Maness, 1989; Biscardi et al., 1991) , and several receptor protein tyrosine kinases (PTKs) (Jelsma et al., 1993; Sajjadi and Pasquale, 1993; Takahashi et al., 1993; Cohen and Fraser, 1994; Escandon et al., 1994; Pasquale et al., 1994; Tcheng et al., 1994; Cheng et al., 1995; McFarlane et al., 1995) and cytoplasmic PTKs are expressed in the developing visual system, including the src family members pp60-",; pp59"-J+'", and p~59"-~~' (Sorge et al., 1984; Mancss et al., 1990; Sugrue et al., 1990; Zhao et al., 1991; Ingraham et al., 1992; Bare et al., 1993; Bixby and Jhabvala, 1993) .
src PTKs may transduce signals from receptors for molecules promoting neurite outgrowth that lack intrinsic tyrosine kinase activity. For example, stimulation of integrins results in an intracellular increase in tyrosine phosphorylation (Hirst et al., 1986; Guan et al., 1991; Kornberg et al., 1991; Guan and Shalloway, 1992 ) which is at least partly attributable to the stable association and activation of ~~60"~"" and another PTK, ~~12.5"'~~ (Lipfert et al., 1992; Fox et al., 1993; Huang et al., 1993; Cobb et al., 1994; Schaller et al., 1994; Schlaepfer et al., 1994; Shattil et al., 1994; Xing et al., 1994) . Cerebellar neurons from src-minus mice extend shorter neurites than controls on Ll substrates (Ignelzi et al., 1994) and N-CAM-mediated neurite outgrowth is impaired in neurons from fin-minus mice (Beggs et al., 1994) . Finally, the cadherin-catenin cell adhesion system is inhibited by II-SYCmediated tyrosine phosphorylation (Matsuyoshi et al., 1992; Behrens et al., 1993; Hamaguchi et al., 1993a) . Thus, ~~60'~"' and pp59'-Jkl are implicated in the signaling pathways of molecules important for axon elongation.
The addition of PTK inhibitors to cultured neurons has yielded diverse effects on neurite outgrowth. Embryonic chicken ciliary ganglion cells sprout more and longer neurites in the presence of genistein and lavendustin A (Bixby and Jhabvala, 1992) suggesting that PTK activity negatively modulates neurite elongation. In contrast, N-CAM-, N-cadherin-, and Ll -stimulated growth of rat ccrebcllar neurons is inhibited by an erbstatin analog and tyrphostins 23 and 25 (Williams et al., 1994) indicating that PTKs promote neurite elongation on these substrates. Finally, neurite outgrowth from PC12 cells stimulated by nerve growth factor (NGF) is increased by genistein and lavendustin A (Miller et al., 1993) but blocked by the more general protein kinase inhibitors K-252a and K-252b (Hashimoto, 1988; . Thus, the precise role of PTK activity in the initiation and extension of neurites from differentiating neurons is not well understood.
We asked whether PTK activity is involved in mediating the extension of retinal axons through the optic tract in viva by pharmacologically inhibiting PTK activity in the intact embryonic brain. We also applied PTK inhibitors to embryonic retinal neurons in culture. Our observations show that herbimycin A and lavendustin A impair the development of retinal projections in viva and retinal neurite outgrowth in vitro. Treatment with these inhibitors in viva, however, does not appear to induce pathfinding errors in the optic tract.
MATERIALS AND METHODS
Embryos. Embryos were obtained from our Xenopus luevis breeding colony at the University of California, San Diego. Embryos from hormone-induced matings were maintained in 10% Holtfrctcr's solution and raised at varying temperatures (14, 17, and 25°C) to obtain a range of developmental stages (Nieuwkoop and Faber, 1967) .
PTKinhibitors and antibodies. Herbimycin A and lavendustin A (Gibco, Grand Island, NY) were resuspended in dimethylsulfoxide (DMSO) and stored in aliquots at -20°C. Lavendustin A was also obtained from Research Biomedicals (Natick, MA). An anti-phosphotyrosine monoclonal antibody, PY20, and a polyclonal antibody against Mek-1 and -2 were purchased from Transduction Laboratories (Lexington, KY). A polyclonal anti-phosphotyrosine antibody, anti-PY, was a gift from Dr. Elena Pasquale (La Jolla Cancer Research Foundation, La Jolla, CA). A monoclonal antibody against the middle and low molecular weight neurofilament proteins, RM0270.7, was a gift from Dr. Virginia Lee (University of Pennsylvania, Philadelphia, PA). A polyclonal antibody against c-.~I% and a control peptide were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Exposed bruin preparation. This method gives cxpcrimcntal access to the developing optic tract and has been dcscribcd previously (Chicn ct al., 1993; McFarlane et al., 1995) . Stage 32 embryos wcrc placed in 100% modified Ringer's solution (MR; pH 7.5) with I% Fungi-Bact (UCSD Core Culture Facility) and 50 pg/ml gentamicin sulfate (Gemini, Calabasa, CA) and anesthetized with MS222 (ethyl-3-amino benzoate methanesulfonic acid salt, Aldrich, Milwaukee, WI; 0.4 mgiml). The left side of the embryonic brain was exposed to the bathing medium by removing the right eye and the skin epidermis overlying the diencephalon, the midbrain and the anterior part of the hindbrain. Ncithcr the contralateral retina nor the optic chiasm area was exposed. After surgery, embryos wcrc placed in 100% MR with 0.3% DMSO in the aresence or absence of PTK inhibitors. Embryos were kept at room tcmpcraturc for 18-24 hr in the dark (PTK inhibitors are light-scnsitivc) until they reached stage 39.
Quantitation of retinal projection lengths. The retinal projection was visualized by anterograde horseradish peroxidasc (HRP Type VI-A peroxidase, Sigma, St. Louis, MO) labeling as described previously (Harris et al., 1985) . Embryos were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 4-24 hr, with overnight fixations done at 4°C. Fixed brains were removed, reacted with diaminobenzidine (Sigma), dehydrated in an alcohol series, and mounted in Permount (Fisher Scientific, Tustin, CA). Brains and projections were drawn at 16X using a camera lucida attachment on a Leitz microscope. Drawings were scanned using a Hewlett Packard ScanJet II, and computer images of the brains were compensated for size and orientation variations using macros previously developed for the National Institutes of Health Image program (Chicn ct al., 1993) . Projection lengths in the contralateral diencephalon were measured from the point of entry into the optic tract (the ventral diencephalon) to the most distal point reached in the pathway. Inhibitortreated projections often comprised a thick mass of short axons with a few sparse axons extending further along the pathway. To reflect accurately the behavior of the majority of axons, sparse longer axons were not included in the length calculations unless four or more wcrc present.
Analysis ofpathjinding Scanned images of control specimens from the herbimycin A cxpcriments wcrc used to create a composite image of a control brain and projection. Computer manipulations of the images were performed using previously developed macros in National Institutes of Health Image (Chicn et al., 1993) . Each sample image was aligned to the same orien;atibn, and samples 'that could 'not be-aligned because of unclear identification of brain landmarks were omitted, leaving a total of 30 specimens. The separate images were combined into a single image, with darker gray colors corresponding to regions of greater overlap. A similar composite was made of 23 specimens treated with 1.3 PM herbimycin A. For comparison of the composite projections, an outline of the control composite projection was positioned in the appropriate location on the treated image.
ImmLlnohistochemistl.
Brains were dissected from experimental embryos after overnight fixation in 4% paraformaldchyde in 0.1 M phosphate butfer at 4°C and processed for immunocytochcmistry as whole mounts. Incubations with the PY20 antibody (3 fig/ml) were done overnight at 4°C and, to control for specificity, some brains were preincubated with 0phospho-t.-tyrosine (2 mM/pg PY20; Sigma). Antibodies were diluted in PBS with 1% Triton X-100 and 0.4% bovine serum albumin (BSA; fraction V, Sigma), and 5510% goat serum was added to block nonspecific binding. A TRITC-conjugated secondary antibody was used (Jackson ImmunoResearch, West Grove, PA), and the brains were mounted in p-phenylene diaminc (pPD glycerol, Sigma). Images of immunolabeled brains were taken with an SIT-650 (Dage MTI) camera mounted on a Nikon Optiphot-2 microscope and digitized in a Macintosh IIfx (Apple Computer, Cupertino, CA) as described previously (Chien et al., 1993) . The same magnification and cxposurc time were used for each sample, and gray values were determined using National Institutes of Health Image macros. Dissociated cultures were stained as above using less (0.3%) Triton X-100.
/-"Slmethionine labeling and trypan blue staining. Control embryos, inhibitor-treated embryos, and embryos treated in 12 kg/ml cycloheximide for 1 hr wcrc incubated for 3 hr in 1 mCi/ml ["S]methionine (specific activity, >lOOO; ICN Radiochemicals, Costa Mesa, CA). Brains were removed and homogenized with a Dounce homogenizer in PBS with 0.1 mg/ml BSA, and proteins were precipitated on ice for 30 min in a final concentration of 10% trichloroacctic acid. Protein precipitates were vacuum-filtered onto Whatman filter paper and counted in a scintillation counter.
Trypan blue cxposcd brains staining was performed by placing live embryos with in 0.5% Trvpan blue (Sigma) for 3-5 min. Brains were ~.
,L, mounted in PBS, and blue cells were counted from the forebrain to the hindbrain in the superficial layers of the ncuroepithelium. In vitro lyrosine kinase ns.sc~y. Exposed brains treated for 4-5 hr with PTK inhibitors were dissected and placed in protease inhibitor buffer [O.l M NaCI, IO mM Tris, pH 7.6, I mM EDTA, pH 8, 2.5% Nonidet P-40, I ITIM sodium orthovanadatc (Sigma), 0.2 trypsin inhibitor units/ml aprotinin (Sigma), I mM phenylmethylsulfonyl fluoride (Sigma), and 25 pg/ml lcupcptin (Sigma)]. Samples were homogenized by pipetting, and aliquots of supernatant were removed after centrifugation to perform a protein concentration assay (Bio-Rad DC Protein Assay, Bio-Rad, Richmond, CA). Irz vifro PTK reactions and ELISA assays were performed in duplicate using the Genius Tyrosinc Kinase Assay Kit (nonradioactive) from Boehringer Mannheim (Indianapolis, IN) according to their protocol. After 3 min, the ELISA reaction was qucnchcd by adding 100 ~1 of 1% SDS to each well, and the absorbance at 405 nm was read.
Western blot analysis. Brains of experimental embryos were placed immediately on ice in a modified RIPA buffer (Schlaepfer et al., 1994) . Samples were homogenized by repeated pipetting and centrifuged, and protein concentration assays (Bio-Rad) were performed on aliquots of the supernatants. Some samples were treated for 30 min with alkaline phosphatase (Pharmacia, Alameda, CA) at a concentration of 2 U/50 ~1. SDS-sample buffer was added, and samples were boiled 4 min before being loaded and run on a 7.5% SDS-polyacrylamide gel (Laemmli, 1970) . Proteins were transferred to nitroccllulose (Towbin et al., 1979) , and membranes were stained with amido black to confirm equal loading of protein. Membranes were dcstaincd, blocked overnight in 3% BSA in Tris-buffered saline (TBS), and incubated for 3-4 hr in 3 &ml anti-PY or the same concentration of antibody prcincubated with IO times the concentration of O-phospho-L-tyrosine.
For anti-c-src and MEK-I and -2 staining, mcmbrancs were blocked in 5% nonfat milk in TBS, and the antibodies were used at a concentration of 1 &ml. After washing in TBS, the mcmbrancs were incubated in protcin A peroxidase (I mg/ml stock solution, Sigma), which was diluted I:5000 in 3% BSA in TBS for l-2 hr. The staining was detected with ECL solutions according to the manufacturer's protocol (Amcrsham, Arlington Heights, IL) using Hyperfilm (Amersham). Dcnsitomctry was performed by scanning the films using a Hewlett Packard ScanJet II and measuring gray levels written in National Institutes of Health Image.
Dissociated Xenopus retinal cultures. Eye primordia from stage 25-27 embryos were dissociated and cultured as described previously (Harris and Messersmith, 1992 ) on coverslips coated with 1 mgiml poly-Lornithine (Sigma) and 10 &ml mouse laminin [Gibco, Sigma, and Upstate Biotechnology (Lake Placid, NY)]. Culture medium was 60% L15 containing 10% fetal bovine serum, 1% embryonic extract, 1% Fungi-Bact (Irvine Scientific, Irvine, CA), and 0.33% DMSO with or without a PTK inhibitor. Cultures were grown in the dark at room temperature, fixed overnight at 4°C in 2% paraformaldehyde, stained with 0.2% toluidine blue (Sigma), and mounted in glycerol. Drawings of individual neurons were made using a 40X phase objective and a camera lucida attachment. Measurements were made on cells identified as retinal ganglion cells based on their rounded morphology, size, and neurofilament-positive staining (RM0270.7 antibody). For the data presented, neurites were measured individually from the edge of the cell body to the most distal tip of the growth cone or axon if there was no growth cont. If a ccl1 had two processes, each was measured separately. For branched processes, the longest continuous length was measured and the short branch was not included. Although not presented, the total neurite length from each cell was also measured in two experiments. The results for both methods of quantitation (individual length and total length) were similar. Camera lucida drawings of growth cones were made on a Zeiss Photomicroscooe (Thornwood, NY) at 100X magnification. The filopodia were identified and counted as described previo&ly (Holt, 1989) . The width of the growth cone was determined by averaging four to eight spaced measurements across the dimension perpendicular to the axon. The length was measured as the longest dimension from the base of the growth cone thickening to the lamellar tip in a direction parallel to the axon. not affected in these areas. The average length of control projections in the contralateral diencephalon was 270 pm, whereas the average length of projections treated with the highest concentrations of the inhibitors was 50 pm (Fig. 2 ). This 80% reduction in projection length demonstrates that PTK inhibition impairs axon elongation in viva.
Reduction in projection length is dose-dependent
A range of concentrations was tested for herbimycin A and lavendustin A to determine their effective dose. The projection length was found to decrease with increasing concentrations of both drugs (Fig. 2) . Maximal inhibition of growth was obtained with herbimycin A at 1.8 PM, and concentrations higher than this did not produce an additional decrease in projection length (data not shown). Lavendustin A also elicited a dose-dependent response although, surprisingly, lavendustin A from different commercial sources produced comparable effects at a different range of concentrations (Fig. 2 ).
Chick ciliary ganglion cultures. Ciliary ganglia from embryonic day 8 chicks were dissected and dissociated with trypsin as described previously (Nishi and Berg, 1981) . They were plated at a density of 1.5 ganglia per culture on laminin-coated coverslius and cultured in Eagle's minimal essential medium containing 10% fetal horse serum, 3% embryonic chick eye extract (Nishi and Berg, 1981) and 0.33% DMSO with or without a PTK inhibitor. Cultures were incubated at 37°C for 4 hr, then fixed in 4% glutaraldehyde and 5% sucrose in PBS for 3 hr at 4°C. Cultures were stained in 0.2% toluidine blue, mounted in glycerol, and examined with bright-field microscopy. Individual neurons were drawn using a camera lucida, and neurite lengths were quantitated as described previously (Bixby and Jhabvala, 1992) .
Effects of herbirnycin A are not attributable to toxicity
To address the possibility that the inhibitory effects of herbimycin A on axon growth were attributable simply to a general toxicity of the drug, we performed three different experiments. First, we checked whether the effects of the drug were reversible. After an initial 8 hr exposure to herbimycin A (stage 32 to 35136) embryos incubated in inhibitor-free solution until stage 39. As shown in RESULTS PTK inhibitors reduce the length of retinal projections cause new axons could have entered the optic tract after removal bath-applied to the diencephalon and midbrain during the period of the drug. Previous studies using cultured cells have docuwhen axons first navigate the optic pathway. We used the exposed mented the reversibility of herbimycin A (also see in vitro data in brain preparation that allows reagents direct access to the intact optic present study) and suggest that the recovery is attributable to de pathway as the retinal axons extend through it to their target (Chien novo synthesis of the target PTKs (Uehara et al., 1989; Garcia et et al., 1993; McFarlane et al., 1995) . Briefly, the skin epidermis and al., 1991). eye were removed from the left side of the head of stage 32 embryos, Second, we evaluated the rate of protein synthesis in the exposing the underlying optic tract and tectum but not the contralatinhibitor-treated brains by measuring the levels of incorporation era1 retina or midline chiasm. At this stage of development, pioneerof [?S]methionine. The rate of protein synthesis in control and ing retinal axons from the contralateral eye have crossed the chiasm treated brains was found to be similar and contrasted with signifand are just beginning to enter the ventral optic tract. The growth icantly lower levels seen in brains treated with cycloheximide cones are positioned very close (-10 pm) to the pial surface (Holt, (control brains: 1.2 X 10" ? 2.8 X lo4 cpm, n = 5; herbimycin A: 1989). Operated embryos were incubated in media in the presence or 1.2 X 10" t 2.2 X lo4 cpm, n = 4; cycloheximide: 3.5 X lo4 5 6.1 absence of PTK inhibitors until stage 39, by which time the retinal X 10" cpm, n = 5). The retina was not assayed because sectioned projection has normally reached the optic tectum (Holt, 1984) . The material of inhibitor-treated embryos showed morphologically projections were visualized by anterograde transport of horseradish normal, mitotically active retinae that retained phosphotyrosine peroxidase (Harris et al., 1985; Cornel and Holt, 1992) .
immunoreactivity (data not shown) and our previous studies have Embryos incubated in herbimycin A or lavendustin A appeared indicated that reagents applied to the brain have little or no access healthy and developed at a rate similar to control embryos; to the contralateral retina (Chien et al., 1993 ; McFarlane et al., however, the retinal projections of the experimental groups were 1995). markedly shorter. In control embryos, 3-4 hr after brain exposure Third, possible increases in cell death in the exposed brain (stage 33/34), the leading retinal axons extended -100 pm along tissue were evaluated using trypan blue, a dye that is excluded the ventral part of the optic tract (Fig. 1A) and, by stage 39, 12-18 from live cells (Durkin et al., 1979) . After exposure to 1.8 PM hr after exposure, retinal projections extended the full length of herbimycin A for 12-18 hr, brains were stained with trypan blue the optic tract and into the optic tectum (Fig. 1B) . This contrasts and the number of labeled cells counted in the exposed area of the with the phenotype observed for both herbimycin A-and lavenbrain. The average number of stained cells present in the exposed dustin A-treated projections, where a majority of the retinal axons side of inhibitor-treated brains (107 ? 15; n = 10) was not failed to extend much beyond the point of entry into the ventral significantly different ('p < 0.05, one-tailed t test) from that found optic tract (Fig. 1C:D) . At the brain entry point and at the optic in control exposed brains (80 ? 15; n = 9). These cells were chiasm, areas that were not surgically exposed to the drug, the sparsely scattered through the forebrain and midbrain regions, projections of control and treated embryos were similar in size and their number represents a small fraction (probably <l%) of and thickness (data not shown), indicating that axon growth was the total number of cells comprising this area. axon elongation in the tract cannot be attributed to elevated cell death in the substrate pathway. Together, these three assays provide strong evidence that inhibition of axon elongation in the optic tract is not attributable to nonspecific drug toxicity.
PTK activity and levels of tyrosine phosphorylation are altered Both herbimycin A and lavendustin A have been shown to reduce the amount of PTK activity in cultured cells and in biochemical assays (Uehara et al., 1986 (Uehara et al., , 1989 Onoda et al., 1989 Onoda et al., , 1990 Fukazawa et al., 1990 Fukazawa et al., , 1991 Uehara and Fukazawa, 1991) . To examine the effectiveness of these drugs at inhibiting PTK activity in intact embryonic CNS tissue, an in vitro kinase assay was performed on crude lysates of whole brains that were first exposed intact to herbimycin A for 4 hr. The substrates for the PTKs were the biotinylated cdc2(6-20) and the gastrin-17 peptides. Each peptide contains a consensus sequence for tyrosine phosphorylation, with the cdc2(6-20) sequence being relatively specific for phosphorylation by src family PTKs (Cheng et al., 1992) . The gastrin-17 sequence is less specific and is phosphorylated by a wide variety of PTKs in vitro (Baldwin et al., 1983) . After the kinase reaction, tyrosine phosphorylation of the peptides was To assess the spatial reduction in tyrosine phosphorylation, we examined exposed whole-mount brains by immunofluorescence with the PY20 anti-phosphotyrosine antibody. Control embryos exhibited a distinct pattern of phosphotyrosine immunoreactivity in the brain during embryonic development that was blocked by 0-phospho-L-tyrosine (data not shown). The tract of the postoptic commissure (TPOC) is an early developing axonal tract in the diencephalon (Easter and Taylor, 1989; Cornel and Holt, 1992) and at stages 33134-35136 the TPOC and other developing axon tracts stain brightly (Fig. 54) . After exposure to herbimycin A or lavendustin A, the intensity of staining in the axon tracts was diminished (Fig. 5B) . To quantitate the amount of reduction, computer images of six herbimycin A-treated and four control immunolabeled brains were captured, and the average gray values quantified with an ELISA assay using an anti-phosphotyrosine antibody, and the results demonstrated a significant decrease in tyrosine phosphorylation for both peptides with respect to control lysates (Fig. 4/l,/? ). The reactions were performed in duplicate, and an average of three experiments gave a reduction in tyrosine phosphorylation of 66 -C 18% with the cdc2(6-20) peptide and an average reduction of 52.7 ? 3.9% for reactions using the gastrin-17 peptide. Control samples lacking ATP averaged a 93% reduction in phosphorylation compared with control reactions (data not shown). In addition, the amount of phosphorylation from lysates of brains that were exposed to herbimycin A during the bath only, or were exposed continuously both in the bath and in the kinase reaction, was compared and found not to be significantly different. In one experiment, sample homogenates were obtained from embryos treated with 50 PM lavendustin A (Research Biomedicals). When compared with controls, these samples had 39% less tyrosine phosphorylation on the cdc2(6-20) peptide and 26% less on the gastrin-17 peptide (data not shown), suggesting that at this concentration lavendustin A may not be as effective as herbimycin A. However, this assay demonstrates that both drugs gain access to the tissue and inhibit PTK activity. In the case of 1.8 PM herbimycin A, a 4 hr exposure results in an -5O-60% decrease in tyrosine phosphorlyation on two peptide substrates.
To demonstrate that herbimycin A effectively alters the levels of tyrosine phosphorylation in the brain, we compared the profile of tyrosine-phosphorylated proteins in control and PTK inhibitortreated brain homogenates using Western blot analysis. Lanes containing exposed control samples had 12 reproducible bands ranging in size from -180 to 28 kDa (Fig. 4C) . After PTK inhibitor treatment, at least eight of the bands had a visible decrease in phosphotyrosine staining (approximate sizes 180, 115, 95,90,85,60,46, and 40 kDa), and one band, at -28 kDa, showed an increase in staining intensity. The average reduction in optical density after densitometric tracing was 40 5 8% for the lane treated with herbimycin A and 30 ? 15% for the lane treated with lavendustin A. The staining was specific, because it could be blocked by competition with the peptide 0-phospho-L-tyrosine or by treatment of the lysates with alkaline phosphatase (data not shown). The 60 kDa phosphotyrosine band observed to be sensitive to the inhibitors is the same molecular size as the PTK src. Consistent with this, when the blot was probed with an antibody against ~~60'."" (which is known to have some cross-reactivity to ~~60"~"' and pp59'-@'), a prominent band at 60 kDa was labeled (Fig. 40) . in the forebrain were compared. Images of treated brains were on average 27 ? 5% less bright than control images.
In cryostat sections of the retina, the retinal ganglion cell (RGC) fiber layer, the inner and outer plexiform layers, and the optic nerve head were brightly labeled with the PY20 antibody at stage 39 (Fig. X) . Cells in the ciliary margins of the retina, which includes the proliferative zone, showed little immunoreactivity. To characterize the pattern of tyrosine phosphorylation in retinal neurites and their growth cones, dissociated retinae cultured on laminin for 8-10 hr were stained with the PY20 antibody. The cell bodies, axons, and growth cones of control retinal cells had punctate labeling, with bright spots frequently extending to the lamellar edges of the growth cones and along filopodia (Fig. 5D) . Herbimycin A-treated retinal cells showed an overall reduction in punctate staining in the body of the growth cone and in filopodia (Fig. 6E) . The persistence of some tyrosine phosphorylation may represent PTK activity not affected by the drugs and/or slow phosphatase-mediated turnover.
Axon steering is not perturbed by PTK inhibitors
Retinal axons normally follow a well defined route through the diencephalon (Holt, 1984; Harris, 1986) . To investigate whether inhibition of PTKs interfered with the ability of axons to steer this route correctly, we assayed the trajectories of inhibitor-treated projections. At low doses of herbimycin A and lavendustin A (0.44 and 0.88 FM herbimycin A; 25 FM RBI lavendustin A), axons grew within the normal boundaries of the optic tract and, in many cases, fibers extended correctly to the optic tectum. In -50% of the cases at high concentrations of both drugs, an additional sparse projection consisting of l-10 axons extended significantly further along the optic tract than a majority of the projection, enabling an assessment of their trajectories. An example is shown in Figure 1E in which a dense bundle of optic fibers crosses the chiasm and abruptly narrows into a sparse projection in the ventral optic tract. In 3 of 108 samples treated with either 1.3 or 1.8 pM herbimycin A, or 75 or 100 PM lavendustin A-the highest drug concentrations-one or two fibers reached as far as the optic tectum (Fig.  1F) . For all concentrations of drugs used, no fibers were found to deviate significantly from the normal pathway. This was supported by a computer-aided analysis of superimposed projections. A composite control brain and projection image was generated by aligning and overlaying computer images of 30 control specimens from the herbimycin A experiments. The resulting image is shown in Figure ti , in which the darker regions of the projection indicate areas of greater overlap between specimens. A similar composite was made of 23 specimens treated with 1.3 PM herbimycin A. This concentration was chosen to maximize the number of sparse axons that elongated beyond the ventral optic tract. When an outline of the control composite projection was superimposed on the experimental composite image, the trajectories of all inhibitor-treated axons were seen to fall within the normal boundaries of the optic tract (Fig. 6B) . This shows that retinal axon steering was not sensitive to the reduced levels of PTK activity achieved with herbimycin A treatment but leaves open the possibility that more specific or efficient PTK inhibition might impair this process.
PTK inhibitors reduce neurite extension in vitro
Although the in viva approach we have used provides a valuable way to challenge axons in their native environment, it has the limitation that the responses seen could be attributable to effects on the neuroepithelial substrate rather than directly on the retinal axons. To address this point, we performed a parallel series of experiments in vitro. Dissociated eye primordia were cultured on laminin substrates in the presence or absence of PTK inhibitors, and neurite outgrowth was measured. Treated cultures appeared healthy, and no qualitative difference in the attachment of cells to laminin was observed. Neurite lengths measured after 10 hr in culture displayed a dose-dependent decrease compared with controls (a summary of neurite lengths obtained in four experiments with herbimycin A is shown in Fig. 7A ). Neurite outgrowth in culture was found to be sensitive to as little as 0.055 PM herbimytin A and, at the maximum dose (1.8 PM herbimycin A), neurite lengths were 70-80% shorter than controls. Neurites in cultures treated with lavendustin A were also found to be shorter than control neurites in a concentration-dependent manner, with a 65-75% reduction in length at the maximum doses used (data not shown). In addition, the effects on neurite lengths with both drugs were found to be reversible (Fig. 7A for herbimycin A; data not shown for lavendustin A). Our finding of 70-80% reduction in outgrowth in vitro correlates with the 80% reduction in projection length in viva and supports the possibility that the drugs directly inhibit axon growth in the embryo.
Inhibitor treatment causes growth cone enlargement
The growth cones of cultured retinal neurons were examined to find out whether PTK inhibition causes morphological changes. In both control and PTK inhibitor-treated cultures, neurites had growth cones with filopodia and lamellipodia.
At 1.8 PM herbimycin A, growth cones were significantly larger than normal (Table 1 , Fig. 7B,C) . The enlargement occurred in both width and length dimensions but was most significant along the length, giving rise to growth cones that were -50% longer than normal (Fig. 7C) . A similar increase in size was also observed in cultures treated with 100 PM Gibco lavendustin A (data not shown). The average number of filopodia did not differ significantly between control and treated growth cones. Thus, diminished PTK activity causes an expansion in growth cone size on a laminin substrate.
PTK Inhibitors elicit opposite response in chick ciliary ganglion neurons Bixby and Jhabvala (1992) found an increase in neurite length and in the number of neurons sprouting neurites after the PTK inhibitors genistein and lavendustin A were applied to cultures of chick ciliary ganglion cells. Because our experiments showed a decrease in neurite length, as a positive control we cultured E8 dissociated chick ciliaty ganglion cells in the presence of genistein and lavendustin A. These neurons showed increases in both the number and the length of neurites extended, a potentiation effect similar to that reported by Bixby and Jhabvala (1992) (Table 2) . Furthermore, herbimycin A, which was not previously used on these neurons, gave the greatest potentiation.
DISCUSSION
We tested the role of PTK activity in growing retinal neurons in two complementary assay systems: the native environment of the developing optic tract, and in vitro on laminin. Our main finding is that retinal axon extension is inhibited in both experimental systems when PTK activity is reduced by treatment with herbimycin A and lavendustin A. This indicates that inhibitorsensitive PTKs normally play a role in promoting the extension of retinal axons through the optic pathway and on laminin. We also show that inhibitor-treated growth cones are significantly c the 60 kDa PTK c-m. Lanes I and 3 appear to contain equivalent amounts of protein, whereas the labeling of the band in lane 2 is slightly less intense, consistent with previous observations that herbimycin A treatment can cause some degradation of ~~60"."" (Uehara et al., 1989; Garcia et al., 1991) . E, Same blot as in C, stained with a polyclonal antibody against the dual-specificity kinases MEKl and -2 to confirm that equal amounts of protein appear to be present with no indication of protein degradation in the herbimycin A-treated lane. larger than normal on laminin, which suggests that PTK activity modulates the size of growth cones in response to substrate interactions. Finally, an interesting aspect of this study is the demonstration that the same PTK inhibitors elicit opposite responses in two different classes of neurons, Xenopus retinal neurons and chick ciliary ganglion neurons. The distinct responses to PTK inhibition may reflect cell-type differences in the activity or expression of PTKs (and/or phosphatases) that are stimulated by laminin.
A potential problem with using pharmacological inhibitors is that they typically affect a range of PTKs (Uehara et al., 1986 (Uehara et al., , 1989 Onoda et al., 1989 Onoda et al., , 1990 Fukazawa et al., 1990 Fukazawa et al., , 1991 Garcia et al., 1991; Uehara and Fukazawa, 1991; Hamaguchi et al., 1993a,b) . We chose herbimycin A and lavendustin A because they effectively inhibit a similar group of receptor and cytoplasmic PTKs, such as the epidermal growth factor receptor (EGFR) and pp60"-"", with only weak effects on the enzymatic activity of protein kinases A or C at high concentrations (Onoda et al., 1989; Garcia et al., 1991; O'Dell et al., 1991; Uehara and Fukazawa, 1991; Li et al., 1993) . They are not structurally related, and they inhibit PTKs by different mechanisms. Lavendustin A competes for the ATP-binding site (Onoda et al., 1989) , whereas herbimycin A hinders PTK activity by covalently binding its PTK target (Uehara et al., 1989; Fukazawa et al., 1990 Fukazawa et al., , 1994 Garcia et al., 1991) . The fact that both of these inhibitors gave similar results in . Herbimycin A inhibits neurite outgrowth and causes enlargement of growth cones in vitro. A, Neurites of dissociated retina1 neurons treated for 10 hr with herbimycin A were measured in four separate experiments, and the data were combined and expressed as a percentage of control neurite outgrowth. The average control neurite length for all four experiments was 230 F 58 km, and 100-300 neurites were analyzed for each concentration. Treated neurites are significantly shorter in a dose-dependent manner. REC (recovery) designates the cultures in which the drug-containing medium was changed to control medium after 5 hr of exposure. **This concentration was analyzed in only a single experiment, in which 70 neurites were measured. B, C, Phase-contrast photomicrographs of retinal neurons cultured for 10 hr with or without herbimycin A and stained with toluidine blue to enhance the contrast. B, Control growth cone (arrowhead) exhibiting typical size and morphology. The neurite is long, and the cell body is out of the field of view. C, Herbimycin A (1.8 PM)-treated neuron has short neurite extending from cell body (cb) and is tipped with an enlarged growth cone (arrowhead). Scale bar, 25 Km. our in vivo and in vitro studies strongly suggests that the underlying cause of impaired axon extension was the direct inhibition of PTK activity.
Previous studies have established that PTK activity is de- creased in cultured cells treated with the same drugs (Uehara et al., 1986 (Uehara et al., , 1989 Yamaki et al., 1989; Fukazawa et al., 1991; Garcia et al., 1091; Li et al., 1993) . The present study documents with three independent lines of evidence that PTK activity is significantly inhibited in brains in viva. First, inhibitor-treated brains show diminished lcvcls of phosphotyrosine immunostaining compared with exposed control brains. Second, at least tight proteins observed in Western blots of inhibitor-treated brain homogenates exhibit rcduccd levels of tyrosine phosphorylation.
Although anti-phosphotyrosine antibody labeling is an indirect method of observing PTK activity, because the phosphorylation state of a protein depends on both PTK and phosphatase activity, the immunofluorescence and Western blot data are consistent with a decrease in PTK activity. Third, PTK activity directly assessed in crude homogenates from brains treated with herbimycin A is reduced by 50-60%. None of the treatments or assays we performed resulted in the complete loss of PTK activity, indicating that some brain PTKs were not sensitive to the drugs (Onoda et al., 1989; Li et al., 1993; Smyth et al., 1093) . Alternatively, the inhibitors may not have reached cells deep in the neuroepithelium.
Although the exposed brain preparation provides an accessible in vivo system, it has the limitation that drugs have access not only to the retinal axons but to their neuroepithelial substrate as well. This raises the question of whether the inhibition of axon out- Dissociated chick ciliary ganglia were plated (in duplicate) in control medium or medium containing a PTK inhibitor and were incubated for 4-6 hr. Between 300 and SO0 cells per culture wcrc counted to determine the percentage of neurons with ncuritcs, ;md the totlll neuritc length per neuron was measured for more than 30 neurons in each culture.
growth seen in vivo resulted from effects on the substrate tissue or the axons. Our studies showed that neurite outgrowth in vitro is reduced to a similar degree as that in vivo, which favors the idea that the inhibitors exert their effects directly on PTKs in the axons. However, it is still possible that some of the in vivo inhibition arises indirectly from effects on, for example, growth promoting molecules in the substrate. At the higher doses of herbimycin A used (1.3 and 1.8 FM), we often found a small group of fibers (l-10) that extended further into the optic tract than the stalled majority. These axons followed the normal pathway without exhibiting pathfinding errors, leading to the conclusion that these PTK inhibitors do not affect the steering decisions of growing retinal axons at concentrations that effectively inhibit axon extension. This observation does not eliminate the possibility that PTKs sensitive to the inhibitors are involved in axon navigation because guidance deficiencies may have been masked by the impairment of elongation. It is not clear why a few axons were able to extend a significant distance into the optic tract whereas most did not. One possibility is that the amount of PTK inhibition varied between individual fibers because of either differences in drug accessibility or intrinsic differences in PTK composition or activity. Another possibility is that some fibers may have been more efficient at responding to cues in the ncuroepithelium that do not require mediation by PTK activity, such as a Ca' ' -or a Ca' ' -calmodulin signaling mechanism (Bixby et al., 1004; VanBerkum and Goodman, 1005) .
Many studies have documented that growth cones undergo morphological changes when they cncountcr ditfcrent substrates in vitro (Lctourncau, 1975; Argiro ct al., 1984; Lcmmon et al., 1902; Burden-Gulley et al., 1995; Fan and Rapcr, 1095 ) and when they enter new microterrains in l~ivo (Bovolenta and Mason, 1987; Holt, 1989; Godcment et al., 1994) . Alterations in growth cone shape have been shown to correlate with different aspects of growth cone behavior such as adhesiveness to the substrate, rate of advancement, and directional orientation; however, the molecular basis underlying these behaviors is poorly understood. The enlargement of retinal growth cones that we observed on laminin with PTK inhibition suggests that tyrosine phosphorylation may regulate growth cone shape and, therefore, possibly behavior. In support of this idea, the PTK FAK, which is present in Xenopus retinal growth cones (Worley and Holt, 1995) , recently has been found to play an important role in regulating the shape and migration of mesodermal and fibroblast-like cells cultured on laminin (Ilic et al., 199.5) .
We were able to show that src family PTK activity was reduced by both drugs in exposed brains using an irz vitro tyrosinc kinasc assay. ~~60'."" is a potentially interesting target because it is present in RGCs and growth cones (Sorge et al., IYX4; Mancss ct al., 1990; Sugruc cl al., 1000) and may mediate signals from molcculcs that arc important for ncurite extension, such as intcgrin (Hirst et al., 1986; Kornberg et al., 1991; Matsuyoshi et al., 1992; Behrens et al., 1993; Hamaguchi et al., 19Y3a,b; Ignelzi et al., 1994; Xing et al., 1994) . Xenopus retinal axon extension is severely inhibited in vivo when integrin function is perturbed by the transgenic expression of chimeric pl integrins (Lilienbaum et al., lY95) , and here we observed that PTK inhibition impairs neurite outgrowth on laminin, an extracellular matrix ligand for certain pl integrin heterodimers. However, neurite extension from cerebellar neurons from transgenic mice null for src or fYn is normal on laminin substrates (Beggs et al., 1994; Ignelzi et al., 1994) . The lack of an effect may reflect functional redundancy between src and fin, which have been reported to phosphorylate overlapping substrates (Sartor and Robbins, 1993; Thomas et al., 1995) . Transgenie mice doubly mutant for src andfivn can survive until birth (Stein et al., 1994) , and studies of embryonic neurite outgrowth in these animals should address this issue further.
Some of the intracellular substrates phosphorylated by activated ~~60"~"" are associated with the actin cytoskeleton, the structure and formation of which are also necessary for the extension of neurites (Sefton and Hunter, 1981; Pasquale et al., 1986; Matten et al., 1990; Wu et al., 1991; Atashi et al., 1992; Reynolds et al., 1992; Wong et al., 1992; Wu and Parsons, 1993) . When the function of one such molecule, vinculin, was blocked in NGF-primed PC12 cells with antisense mRNA, neurites were shorter and growth cones larger in size than controls on a laminin substrate (Varnum-Finney and Reichardt, 1994 ). This phenotype is very similar to the one reported here when cultured neurites were exposed to herbimycin A and lavendustin A. Therefore, the effects of PTK inhibition on the developing retinal projection in Xenopus may be attributable in part to the inhibition of ~~60"~"" signaling from cell-surface molecules to cytoskeletal substrates.
Many extracellular and intracellular molecules have been found to be important for promoting neurite elongation in culture. To determine the functional role that each plays in signaling the extension of axons toward their targets, these molecules and their activities need to be tested in viva. Our observations of the effects of PTK inhibition on optic axon growth in vivo provide evidence that the regulation of tyrosine phosphorylation is involved in retinal axon extension, and we suggest that ~~60".""' may be one of the PTKs active in this signaling cascade.
